|
Gene Therapy
Citations 191-200 of 434 total displayed.
|
Past content
(since Aug 1998):
|
Inhibition of restenosis by tissue factor pathway inhibitor: in vivo and in vitro evidence for suppressed monocyte chemoattraction and reduced gelatinolytic activity
- Christoph W. Kopp, Thomas Hölzenbein, Sabine Steiner, Rodrig Marculescu, Helga Bergmeister, Daniela Seidinger, Isabella Mosberger, Christoph Kaun, Manfred Cejna, Reinhard Horvat, Johann Wojta, Gerald Maurer, Bernd R. Binder, Johannes M. Breuss, Rupert C. Ecker, Rainer de Martin, and Erich Minar
Blood 2004; 103: 1653-1661.
[Abstract]
[Full text]
[PDF]
Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential
- Alexandra Peister, Jason A. Mellad, Benjamin L. Larson, Brett M. Hall, Laura F. Gibson, and Darwin J. Prockop
Blood 2004; 103: 1662-1668.
[Abstract]
[Full text]
[PDF]
Total correction of hemophilia A mice with canine FVIII using an AAV 8 serotype
- Rita Sarkar, Renee Tetreault, Guangping Gao, Lili Wang, Peter Bell, Randy Chandler, James M. Wilson, and Haig H. Kazazian, Jr
Blood 2004; 103: 1253-1260.
[Abstract]
[Full text]
[PDF]
Pharmacologically regulated Fas-mediated death of adoptively transferred T cells in a nonhuman primate model
- Carolina Berger, C. Anthony Blau, Meei-Li Huang, John D. Iuliucci, David C. Dalgarno, Joëlle Gaschet, Shelly Heimfeld, Tim Clackson, and Stanley R. Riddell
Blood 2004; 103: 1261-1269.
[Abstract]
[Full text]
[PDF]
Transient in vivo selection of transduced peripheral blood cells using antifolate drug selection in rhesus macaques that received transplants with hematopoietic stem cells expressing dihydrofolate reductase vectors
- Derek A. Persons, James A. Allay, Aylin Bonifacino, Taihe Lu, Brian Agricola, Mark E. Metzger, Robert E. Donahue, Cynthia E. Dunbar, and Brian P. Sorrentino
Blood 2004; 103: 796-803.
[Abstract]
[Full text]
[PDF]
Helper-dependent adenoviral vectors mediate therapeutic factor VIII expression for several months with minimal accompanying toxicity in a canine model of severe hemophilia A
- Brian D. Brown, Chang Xin Shi, Sandra Powell, David Hurlbut, Frank L. Graham, and David Lillicrap
Blood 2004; 103: 804-810.
[Abstract]
[Full text]
[PDF]
Highly efficient expression of transgenic proteins by naked DNA-transfected dendritic cells through terminal differentiation
- Adriana T. Larregina, Adrian E. Morelli, Olga Tkacheva, Geza Erdos, Cara Donahue, Simon C. Watkins, Angus W. Thomson, and Louis D. Falo, Jr
Blood 2004; 103: 811-819.
[Abstract]
[Full text]
[PDF]
Induction of cytotoxic T-lymphocyte responses to enhanced green and yellow fluorescent proteins after myeloablative conditioning
- Julia C. Morris, Melissa Conerly, Bobbie Thomasson, Jan Storek, Stanley R. Riddell, and Hans-Peter Kiem
Blood 2004; 103: 492-499.
[Abstract]
[Full text]
[PDF]
Lentivector-mediated clonal tracking reveals intrinsic heterogeneity in the human hematopoietic stem cell compartment and culture-induced stem cell impairment
- Frédéric Mazurier, Olga I. Gan, Joby L. McKenzie, Monica Doedens, and John E. Dick
Blood 2004; 103: 545-552.
[Abstract]
[Full text]
[PDF]
Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1
- Valder R. Arruda, Joerg Schuettrumpf, Roland W. Herzog, Timothy C. Nichols, Nancy Robinson, Yasmin Lotfi, Federico Mingozzi, Weidong Xiao, Linda B. Couto, and Katherine A. High
Blood 2004; 103: 85-92.
[Abstract]
[Full text]
[PDF]
|
|
